[HTML][HTML] Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access
I Khalil, R Walker, CK Porter, F Muhib, R Chilengi… - Vaccine, 2021 - Elsevier
Diarrhoeal disease attributable to enterotoxigenic Escherichia coli (ETEC) causes
substantial morbidity and mortality predominantly in paediatric populations in low-and …
substantial morbidity and mortality predominantly in paediatric populations in low-and …
[PDF][PDF] Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries
World Health Organization - Weekly Epidemiological Record …, 2006 - apps.who.int
World Health Organization.( 2006). Future directions for research on enterotoxigenic
Escherichia coli vaccines for developing countries= Orientations futures de la recherche sur …
Escherichia coli vaccines for developing countries= Orientations futures de la recherche sur …
[HTML][HTML] Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)
I Khalil, JD Anderson, KH Bagamian, S Baqar… - Vaccine, 2023 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is one of the leading bacterial causes of diarrhoea,
especially among children in low-resource settings, and travellers and military personnel …
especially among children in low-resource settings, and travellers and military personnel …
Vaccines against enterotoxigenic Escherichia coli
AM Svennerholm, J Tobias - Expert review of vaccines, 2008 - Taylor & Francis
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea among children less
than 3 years of age in developing countries and in travelers to these areas. The key …
than 3 years of age in developing countries and in travelers to these areas. The key …
[HTML][HTML] Status of vaccine research and development for enterotoxigenic Escherichia coli
AL Bourgeois, TF Wierzba, RI Walker - Vaccine, 2016 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is one of the most common bacterial causes of
diarrhea-associated morbidity and mortality, particularly among infants and young children …
diarrhea-associated morbidity and mortality, particularly among infants and young children …
Enterotoxigenic Escherichia coli Infections
JM Fleckenstein, FM Kuhlmann - Current infectious disease reports, 2019 - Springer
Abstract Purpose of Review Review recent developments pertaining to the epidemiology,
molecular pathogenesis, and sequelae of enterotoxigenic Escherichia coli (ETEC) infections …
molecular pathogenesis, and sequelae of enterotoxigenic Escherichia coli (ETEC) infections …
Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans
Diarrhea is the second leading cause of death in children younger than 5 years.
Enterotoxigenic Escherichia coli (ETEC) strains are the most common bacterial cause of …
Enterotoxigenic Escherichia coli (ETEC) strains are the most common bacterial cause of …
Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease
RI Walker, D Steele, T Aguado… - Vaccine, 2007 - Elsevier
Enterotoxigenic Escherichia coli (ETEC) is the most common bacterial cause of diarrhoea in
the world, annually affecting up to 400,000,000 children under 5 years of age living in …
the world, annually affecting up to 400,000,000 children under 5 years of age living in …
Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study
H Steinsland, P Valentiner-Branth, HK Gjessing… - The Lancet, 2003 - thelancet.com
Summary Background Enterotoxigenic Escherichia coli (ETEC) are an important cause of
diarrhoea and diarrhoeal deaths in children living in developing countries and of travellers' …
diarrhoea and diarrhoeal deaths in children living in developing countries and of travellers' …
Vaccines for enterotoxigenic Escherichia coli: current status
EC Boedeker - Current opinion in gastroenterology, 2005 - journals.lww.com
Although new vaccines are being developed to improve immunogenicity over that of the
heat-killed vaccine, the current strategy for antigen inclusion has been challenged and new …
heat-killed vaccine, the current strategy for antigen inclusion has been challenged and new …
相关搜索
- priority activities product development
- priority activities escherichia coli
- development of vaccines escherichia coli
- priority activities global access
- product development global access
- global access escherichia coli
- natural infections escherichia coli
- development of vaccines progress and hurdles
- progress and hurdles escherichia coli
- product development escherichia coli
- hurdles in the development escherichia coli